Mega Rounds: AI Infrastructure and Space Tech Dominate
The largest checks of the week went to companies building foundational technical layers rather than consumer-facing products, a pattern that has held for much of 2026.
- Temporal Technologies, $550M, undisclosed lead. The AI infrastructure company took the top spot for the week in the US market.
- Impulse Space, $308M, undisclosed lead. The space vehicle developer secured the second-largest US round, continuing a string of large bets on commercial space logistics.
- Open Cosmos, approximately $330M (EUR 300M), undisclosed lead. The European satellite operator raised one of the largest European space rounds tracked this week, with tech.eu noting the raise alongside warnings about Europe's risk of marginalisation in the space sector.
Growth Stage: Health Data, Cloud Infrastructure, and Semiconductors
Several growth-stage companies across Europe closed meaningful rounds tied to platform contracts or government frameworks.
- Penelope Health, approximately $100M (EUR 87M), committed by Thoreau. The London-based real-time provider and payer policy intelligence platform also announced a partnership with Thoreau to build a shared layer for real-time payments and clinical rules, covering 200 million patients.
- TUSK IC, EUR 15M, led by Matterwave Ventures, FORWARD.one, and the Flanders Future Tech Fund. The Antwerp-based fabless semiconductor company spun out of KU Leuven will use the capital to move its Ka-band satellite chips into mass production.
- Cycloid, undisclosed Series A. The Paris-based Internal Developer Portal company secured a contract to serve as the developer-facing portal for the European Commission's new six-year, EUR 180M sovereign cloud framework, giving up to 5,000 developers access to cloud services from four European providers.
Drug Discovery: AI-Driven Bets at Multiple Stages
AI-powered drug discovery attracted capital at both the early and late ends of the funding spectrum this week.
- A UK drug discovery startup (unnamed in current reporting) is in talks with the UK Sovereign AI Fund as part of a GBP 500M raise, according to Sifted. Details on the company and lead investor have not yet been confirmed.
- Big Picture Bio, EUR 2.55M, pre-seed co-led by Kadmos Capital and Exceptional Ventures, plus EUR 815K in non-dilutive grant support. The London-based biotech is developing AI-designed combination therapies for cancer and other complex diseases.
Seed Stage: Safety, Cybersecurity, and MedTech
Earlier-stage companies across Europe and Africa closed rounds focused on physical security, cybersecurity, and medical devices.
- Arcos, EUR 5.5M seed, led by High-Tech Grunderfonds (HTGF), with participation from Bayern Kapital, Pact, Haufe, Robin Capital, and strategic angels. The Munich-based startup builds and operates civil security infrastructure across Europe.
- Aeon, $1M, led by Terra Industries. The African cybersecurity company will use the funding to develop products and convert existing pilots with financial services and cloud infrastructure clients into commercial deployments.
- Phosphoenix, EUR 1.3M, supported by existing investors including TTT Medtech Fund. The Amsterdam-based MedTech company is preparing for its first-in-human clinical study of a neuroprosthetic system for people with profound blindness.
Editorial Perspective
This week's raises reflect a market that is concentrating large capital into foundational layers: AI compute orchestration, satellite hardware, and health data infrastructure. At the same time, seed activity in Europe and Africa shows that investors are still writing early checks for physical-world problems, from civil security to sensory restoration. The pairing of a potential GBP 500M drug discovery raise with a tiny EUR 2.55M pre-seed in the same sector illustrates how wide the funding distribution has become. Investors appear willing to bet at both extremes, but the middle of the market, growth-stage companies without a government contract or platform anchor, continues to face the tightest conditions.